A Point-of-care Electrochemical-based Device for Rapid Detection of Fibrinogen on Type A Aortic Dissection Surgery
Recruiting now
Conditions studied: Hypofibrinogenemia
In brief
This study compares the results of the existing fibrinogen concentration monitoring technology to the Electrochemical-based device, a point-of-care and rapid method,using a small amount of extra blood obtained in Type A Aortic Dissection Surgery.
Key facts
- Study ID
- NCT06434389
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- People needed
- 150
- Starts
- 2024-06-01
- Expected to finish
- 2025-10-31
- Last updated by the study team
- 2025-05-15
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Subject underwent surgery for acute type A aortic dissection at our hospital, Subject is 18 years, Subject requires routine TEG measurement, Subject use human fibrinogen concentrate during surgery.
You may not qualify if…
- Use Extracorporeal Membrane Oxygenation after surgery, inability to obtain written informed consent
Where it is running
- The Second Affiliated Hospital of Zhejiang University anesthesiology department — Hangzhou, Zhejiang, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.